Recent Updates
Recently added Catalysts
VNDA Positive Sentiment

Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026

Key Takeaway: Vanda Pharmaceuticals will release its third quarter 2026 financial results on October 28, 2026. A conference call is scheduled for 4:30 PM ET to discuss these results and other corporate activities. Investors can participate by dialing the provided numbers and will have access to a replay of the call afterward.

Market Sentiment Analysis

POSITIVE FACTORS

  • Vanda Pharmaceuticals will announce Q3 2026 results.
  • Management will discuss financial results and corporate activities.
  • Conference call will be accessible to investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
11%
average across 14 past catalysts
Cash runway
~14 mo
Low dilution risk
Lead asset
Imsidolimab
NDA/BLA · Generalized Pustular Psoriasis

Full Press Release Details

Conference Call and Webcast to Follow

WASHINGTON, Oct. 21, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2026 on Wednesday, October 28, 2026, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, October 28, 2026, during which management will discuss the third quarter 2026 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 1178705.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, October 28, 2026, beginning at 8:30 PM ET and will be accessible until Wednesday, November 4, 2026, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 1178705.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:

Frequently Asked Questions

When will Vanda announce its Q3 2026 results?

Vanda will announce its Q3 2026 results on October 28, 2026.

What time is the conference call for Q3 results?

The conference call is scheduled for 4:30 PM ET on October 28, 2026.

How can I participate in the conference call?

Dial 1-800-715-9871 for domestic or 1-646-307-1963 for international access.

Will there be a replay of the conference call?

Yes, a replay will be available starting at 8:30 PM ET on October 28.

Last updated: Oct 21, 2026